Home/Evommune/Jeegar Patel
JP

Jeegar Patel

Chief Scientific Officer

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2